Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02537223
Title Phase I Study of BYL719 in Combination With Cisplatin and Radiotherapy in Patients With Squamous Cell Head and Neck Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University Health Network, Toronto
Indications

head and neck squamous cell carcinoma

Therapies

Alpelisib

Cisplatin

Age Groups: adult
Covered Countries CAN


No variant requirements are available.